Stem Cell Research
Transcription factor MEF/ELF4 regulates quiescence of primitive hematopoietic cells
Published in Gene Therapy Weekly, May 25th, 2006
According to a study from the United States, "The transcriptional circuitry that regulates the quiescence of hematopoietic stem cells is largely unknown.
"We report that the transcription factor known as MEF (or ELF4), which is targeted by the t(X;21)(q26;q22) in acute myelogenous leukemia, regulates the proliferation of primitive hematopoietic progenitor cells at steady state, controlling their quiescence."
"Mef null HSCs display increased residence in G0 with reduced 5-bromodeoxyuridine incorporation in vivo and impaired cytokine-driven...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-05-25)
More Articles from Gene Therapy Weekly
- Geriatrics
Somatic gene transfer of CREB attenuates memory impairment in aging rats - Hepatitis C Virus
Alpha-glucosidase inhibitors restrict binding properties of HCV-like particles - Neuroscience
Thermal hyperalgesia is aggravated by down-regulation of GFR alpha-1 expression - Virology
Dengue virus resistance engineered in genetically modified Aedes aegypti - Adenocarcinoma
Lung adenocarcinoma cells may be targeted by short hairpin RNA targeting EGFR - Adenoviral Vector
Replication properties of human adenovirus in different animal species described - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
